These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31095822)

  • 1. Appraising risk in active surveillance of localized prostate cancer.
    Hogden A; Churruca K; Rapport F; Gillatt D
    Health Expect; 2019 Oct; 22(5):1028-1039. PubMed ID: 31095822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative study.
    Rapport F; Hogden A; Gurney H; Gillatt D; Bierbaum M; Shih P; Churruca K
    BMJ Open; 2017 Oct; 7(10):e017372. PubMed ID: 28982830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
    Rittenmeyer L; Huffman D; Alagna M; Moore E
    JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study.
    Brooks JV; Ellis SD; Morrow E; Kimminau KS; Thrasher JB
    Am J Mens Health; 2018 Sep; 12(5):1719-1727. PubMed ID: 29973123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.
    Mader EM; Li HH; Lyons KD; Morley CP; Formica MK; Perrapato SD; Irwin BH; Seigne JD; Hyams ES; Mosher T; Hegel MT; Stewart TM
    BMC Urol; 2017 May; 17(1):35. PubMed ID: 28482875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
    Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
    Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.
    Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
    Eur Urol Oncol; 2018 May; 1(1):37-45. PubMed ID: 31100227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence clinicians' decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study.
    Lowenstein LM; Choi NJ; Hoffman KE; Volk RJ; Loeb S
    BMJ Open; 2021 Nov; 11(11):e048347. PubMed ID: 34772748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and enablers of active surveillance for prostate cancer: a qualitive study of clinicians.
    Pattenden TA; Thangasamy IA; Ong WL; Samaranayke D; Morton A; Murphy DG; Evans S; Millar J; Chalasani V; Rashid P; Winter M; Vela I; Pryor D; Mark S; Loeb S; Lawrentschuk N; Pritchard E
    BJU Int; 2024 Feb; 133 Suppl 3():48-56. PubMed ID: 37696615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
    Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
    Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
    Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
    BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
    O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
    Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.
    Myers RE; Leader AE; Censits JH; Trabulsi EJ; Keith SW; Petrich AM; Quinn AM; Den RB; Hurwitz MD; Lallas CD; Hegarty SE; Dicker AP; Zeigler-Johnson CM; Giri VN; Ayaz H; Gomella LG
    J Cancer Educ; 2018 Feb; 33(1):180-185. PubMed ID: 27418065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.
    Hoffman RM; Lobo T; Van Den Eeden SK; Davis KM; Luta G; Leimpeter AD; Aaronson D; Penson DF; Taylor K
    Med Decis Making; 2019 Nov; 39(8):962-974. PubMed ID: 31631745
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-Term Cancer Specific Anxiety in Men Undergoing Active Surveillance of Prostate Cancer: Findings from a Large Prospective Cohort.
    Marzouk K; Assel M; Ehdaie B; Vickers A
    J Urol; 2018 Dec; 200(6):1250-1255. PubMed ID: 29886089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing clinical progression and need for treatment in patients on active surveillance for prostate cancer.
    Goldberg H; Klaassen Z; Chandrasekar T; Fleshner N
    Curr Opin Urol; 2018 Jan; 28(1):46-54. PubMed ID: 29028765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial aspects of active surveillance.
    Kazer MW; Psutka SP; Latini DM; Bailey DE
    Curr Opin Urol; 2013 May; 23(3):273-7. PubMed ID: 23422588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC.
    Botejue M; Abbott D; Danella J; Fonshell C; Ginzburg S; Guzzo TJ; Lanchoney T; Marlowe B; Raman JD; Smaldone M; Tomaszewski JJ; Trabulsi EJ; Uzzo RG; Reese AC
    J Urol; 2019 May; 201(5):929-936. PubMed ID: 30720692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
    Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
    BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.